Meta-analysis of the rs2046210 in association with breast cancer risk under different genetic models.

aIncluded a study that only offered the adjusted ORs for AG vs. GG, AA vs. GG and dominant model, both crude and adjusted ORs were combined.bCompared to cases with ER positive cancer, crude OR(95% CI) for ER negative cancer was 1.11(1.06–1.15) for the model of A VS. G (P = 8.27×10−7).cCompared to premenopausal cases, crude OR(95% CI) for postmenopausal cases was 0.99(0.95–1.04) for the model of A VS. G (P = 0.706).